about
Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical AspectsThe endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeabilityDrug reaction with herbal supplement: a possible case of drug induced lupus erythematosus.Isoniazid in autoimmunity: a trigger for multiple sclerosis?Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.Drug-induced lupus: an update on its dermatologic aspects.Lupus: an overview of the disease and management options.Adalimumab-induced lupus serositis.Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α.Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus().Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agentsCarbimazole-induced lupus.Disseminated tuberculosis in a patient with antinuclear antibody-negative systemic lupus erythematosus: a rare associationThe skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis.Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo ClinicIsoniazid Induced Lupus Presenting as Oral Mucosal Ulcers with Pancytopenia.Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis.Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.The renal biopsy in the genomic era.Drug-induced lupus associated with rifabutin: a literature review.Exacerbation of latent lupus: is the culprit acid-fast bacilli or antitubercular therapy?TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced.Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role.Immune-mediated reactions to anti-tumor necrosis factors in inflammatory bowel disease.Anti-thyroid drug-induced lupus: a case report and review of the literature.A case of drug-induced lupus erythematosus secondary to trimethoprim/sulfamethoxazole presenting with pleural effusions and pericardial tamponade.Drug-induced myopathy in a patient with pulmonary tuberculosis.Systemic lupus erythematosus in Crohn's disease: drug-induced or idiopathic?[Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine].[Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].Rifampicin-induced lupus erythematosus.Drug-Induced Lupus Erythematosus Associated with Antiretroviral Therapy in a Patient with Human Immunodeficiency Virus: A Case Report.Orofacial manifestations of adverse drug reactions: a review study.Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis
P2860
Q27023280-BDE98346-E791-497F-81E5-D42EA0E1AA94Q28649846-C76B598A-E3C8-4C8D-91CE-976DFC6DDB22Q34220794-387CE886-CDE4-43D3-9DBA-8E882EA9C730Q34389312-66429BA7-9C91-4D4C-83EC-8CFB418A866EQ34605279-32902E2F-9034-4D5D-925F-7B94ECC7C117Q34611958-C231C808-FAA9-4660-B1D9-078C69036C3FQ34638296-AAABB29B-D140-4ED8-BE15-E4607E833D28Q35203953-DCFC8878-DCE9-44B1-9DA3-403CCE989F2FQ35808834-EE34A715-EC90-40C0-A205-8211BEA5C143Q36418745-C4A0E8B6-BAC1-4FDC-8DFE-D62A33286770Q36579988-0563E3A6-7094-407D-8047-84DA22BC5552Q36703729-5FD8581D-73FF-4ADF-9090-FEFEFC00C052Q36704813-EED6541B-2939-4B32-8070-CB12FE352162Q37196596-56CE0644-1200-48AE-BB6C-934DB7A3968DQ37406698-27BC6CCB-D281-45B9-8D0B-93B92662944FQ37435557-5D8E0F7B-0A5F-46C6-BD60-423481482CCBQ37474498-33AB000A-8D7B-483C-9F64-F6233A862C9CQ37947682-35E36754-5585-4EE8-9691-E302314013DFQ38016064-18E15DFA-E878-41A4-A542-9D4412E0DEE4Q38062343-AF3CC488-2763-495D-891D-7BC670C11C61Q38084786-FE604743-5B35-44E0-8EE1-F4982FAF48DEQ38097710-D614A8A3-48D3-489F-9B40-9E4426054DE3Q38125529-17C29ED8-B04D-4E7E-9CAE-BB2E4708C860Q38190033-756ADC24-B259-4805-A0B3-24C29E1B2B32Q38225438-06F6ED02-C0C5-4DD3-A959-BED954DB68D9Q38315640-B34C1AA6-842F-4AD3-BDC5-EC35FEE42656Q38595655-06908B09-A5DE-4412-B4ED-08601D6D2824Q40631494-179074F5-7447-4FC5-9575-F6C1756D3395Q41106882-0E94BA1A-C0ED-4538-90BD-BB7B6D336E0DQ41832003-32BCA9F9-C780-49BF-A459-EDF2CD1E64EFQ41922650-D0152687-C4EE-4EA3-9CB6-7C63DF138777Q44746734-A3B11829-6F9F-4BF2-9636-572AF5131C39Q44791827-D3D76FFF-FDF1-441E-B6C1-9ABAE8D5E45BQ45324720-34ED889A-0132-4024-BA95-A45747307C07Q50024380-82B6BB2A-DAD7-47AF-8C5A-9041273FF7CCQ59182492-E3E4A9C5-E4CC-44E5-8E9F-4BC5CCC7433C
P2860
description
im November 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2006
@uk
name
Drug-induced lupus: an update
@en
Drug-induced lupus: an update
@nl
type
label
Drug-induced lupus: an update
@en
Drug-induced lupus: an update
@nl
prefLabel
Drug-induced lupus: an update
@en
Drug-induced lupus: an update
@nl
P2860
P356
P1433
P1476
Drug-induced lupus: an update
@en
P2093
P2860
P304
P356
10.1177/0961203306070000
P577
2006-11-01T00:00:00Z